SCHEMBL30387716

SCHEMBL30387716

Nc1ncnc2[nH]nc(-c3cccc(Oc4ccccc4)c3)c12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 9/20 0.65
PIK3CA P42336 9/20 0.65
PIK3CB P42338 9/20 0.65
PIK3CG P48736 9/20 0.65
PRKDC P78527 9/20 0.65
NUDT14 O95848 2/20 0.52
NUDT5 Q9UKK9 2/20 0.52
TEK Q02763 2/20 0.47
KDR P35968 2/20 0.47
LCK P06239 1/20 0.47
BTK Q06187 7/20 0.45
FLT1 P17948 1/20 0.41
ABL1 P00519 2/20 0.41
EGFR P00533 2/20 0.41
SRC P12931 2/20 0.41
HCK P08631 1/20 0.41
MTOR P42345 1/20 0.41
EPHB4 P54760 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
CDK1 P06493 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL200349 0.88 NUDT14 (0.62) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
Hydrochloric Acid SCHEMBL29439185 0.87 NUDT14 (0.61) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL145785 0.86 SRC (0.56) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL21048477 0.85 PIK3CD (0.67) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL15613551 0.85 LCK (0.52) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL19414398 0.84 MAP4K4 (0.54) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL408618 0.83 PIK3CD (0.55) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL15613541 0.83 BTK (0.60) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL14617841 0.83 BTK (0.52) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL11149 0.82 BTK (0.51) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230111917-A1 KINASE ANTAGONISTS UNIV CALIFORNIA (US) 2023-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230111917-A1 KINASE ANTAGONISTS MTOR, RPS6KA3, AKT3 PIK3CD 12/4885PIK3CA 4/4885PIK3CB 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.